A severe shortage of Primaquine – a critical anti-malaria drug to treat malaria and prevents it from coming back after treatment (relapse) is a cause of concern among health authorities in Western Province.
This came as malaria cases continue to experience a resurgence of malaria cases in Gizo and surrounding communities.
Reports from Gizo Hospital confirmed that the essential medication, which is vital for treating Plasmodium vivax malaria infections, has been out of stock for several several months now .
This shortage has left patients vulnerable and increased the risk of further transmission.
Health officials warned that without timely access to Primaquine, patients may suffer recurrent infections, prolonging illness and burdening the already strained healthcare system.
“We are seeing an increase in malaria cases, and the lack of Primaquine is a major challenge for effective treatment,” one of the doctors assisting the Out Patient at Gizo Hospital told Solomon Star.
“Most of the patients which are up to 70% are coming to check their blood and most results came out positive – Plasmodium vivax (PV),” the doctor said.
“Alternative drugs are limited and not as effective in preventing relapses,” he added.
The shortage is reportedly linked to delays in supply chains and procurement processes.
Authorities are urging the Ministry of Health and Medical Services (MHMS) to fast-track delivery of the drug to prevent a public health crisis.
Community leaders are also calling on residents to take preventive measures, such as using mosquito nets and clearing breeding sites, while the health system works to restore stock levels.
Meanwhile, most affected patients with malaria were also being advised to go to a nearby private clinic that sold Primaquine at cost of $100 per packet.
By ULUTAH GINA
Solomon Star, Gizo
